NCT02191813View on ClinicalTrials.gov

Study to Determine the Ability of Seresis to Act as a Skin Protection Agent in Healthy Young Female Volunteers

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 31, 2000

Primary Completion Date

July 31, 2000

Conditions
Healthy
Interventions
DRUG

Seresis®

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY